DONNA KASPER: Open Payments
NPI 1568647030 · OPELOUSAS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 25 payments from 10 companies in 2025. Trend: 2023 $587 · 2024 $716 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 9 | $194 |
| Janssen Scientific Affairs, LLC | 1 | $135 |
| UROGEN PHARMA, INC. | 3 | $104 |
| Janssen Biotech, Inc. | 5 | $96 |
| Boston Scientific Corporation | 2 | $40 |
| PFIZER INC. | 1 | $25 |
| Ferring Pharmaceuticals Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| TOLMAR, INC. | 1 | $20 |
| Endo USA, Inc. | 1 | $16 |
Products named: ERLEADA, GEMTESA, JELMYTO, XTANDI, ADSTILADRIN, Axonics, LYNPARZA, JATENZO.
Industry payments across LA — which companies pay providers there.
